ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CSN Chesnara Plc

257.00
0.00 (0.00%)
22 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Chesnara Plc LSE:CSN London Ordinary Share GB00B00FPT80 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 257.00 258.00 261.50 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Life Insurance -1.11B -98.33M -0.6537 -4.00 393.38M

Chesnara PLC Update on AGM Voting (4553T)

15/11/2023 7:00am

UK Regulatory


Chesnara (LSE:CSN)
Historical Stock Chart


From Oct 2023 to Apr 2024

Click Here for more Chesnara Charts.

TIDMCSN

RNS Number : 4553T

Chesnara PLC

15 November 2023

 
 
 
   LEI Number: 213800VFRMBRTSZ3SJ06 
 

15(th) November 2023

CHESNARA plc

("Chesnara", the "Company" or the "Group")

RESPONSE TO VOTING RESULTS AT 2023 ANNUAL GENERAL MEETING

In accordance with Provision-4 of the UK Corporate Governance Code, Chesnara (CSN.L), the European life insurance consolidator, today provides an update to our statement of 16(th) May 2023 regarding the result of the poll vote at the 2023 Annual General Meeting ("AGM") on Resolution-2 to approve the Directors' Remuneration Report.

Resolution-2 passed with 72.66% of votes in favour. Since the AGM, the Remuneration Committee has engaged with the Company's major shareholders and proxy agencies to help understand the reasons for votes cast against Resolution-2. Three areas have been identified, which are in line with those raised by proxy investor bodies in their respective reports published just in advance of the 2023 AGM. We set them out below, alongside the proposed response to each.

LTIP to be Based One Third on Surplus Emergence

One area of feedback related to the use of cash generation metrics in both the Short Term Incentive Scheme ("STIS") and Long Term Incentive Plan ("LTIP"). In response to this, for LTIP awards granted in FY24, the Commercial Cash Generation metric will be replaced by a new Surplus Emergence metric. The existing relative TSR and Economic Value growth metrics will be retained. Each metric will be weighted one third of the assessment in line with the current approach.

Surplus Emergence will be one of the Group's KPIs and will be consistent with the definition used for reporting elsewhere in the annual report and the Company's other trading updates. It represents the operational surplus that has been generated in the period, largely a function of the movement in the solvency position of the insurance subsidiaries within the Group and takes account of the buffers that management has set to hold over and above the solvency requirements imposed locally by our regulators.

All LTIP Performance Targets to be Disclosed Prospectively

Shareholders expressed a preference for LTIP performance targets to be disclosed prospectively, in line with the approach the Company has always taken for the relative TSR metric. The Company acknowledges that this is increasingly common practice and going forward will disclose threshold targets prospectively going forwards, commencing with the targets for the LTIP awards to be granted in 2024.

Assessment of the Company's M&A Activity Within the Strategic Scorecard of the STIS

For 2024, the Remuneration Committee is proposing to make a small modification to the performance measures to be included in the STIS. The Strategic Scorecard (30% weighting) will be replaced by an ESG metric (5% weighting) and a Strategic Activity Scorecard (25% weighting) which focuses on the assessment of value-enhancing strategic activities including M&A, management actions, operational programme delivery and pipeline development. The weightings within the Strategic Activity Scorecard will vary year-to-year to reflect the relative priorities for the Company.

This means the assessment of M&A activity for the FY24 STIS will be entirely contained within the Strategic Activity Scorecard with no discretion applied. Full details of the assessment of the Strategic Activity Scorecard will be included in the Directors' Remuneration Report each year.

The Remuneration Committee would like to thank the major shareholders who have engaged in the consultation exercise since the AGM and believes that the proposed changes address the key issues raised. In accordance with the Corporate Governance Code, a final summary will be provided in the Company's 2023 Annual Report.

For further information, please contact:

Investor Enquiries

Sam Perowne

Head of Strategic Development & Investor Relations

Chesnara plc

E - sam.perowne@chesnara.co.uk

Media Enquiries

Roddy Watt

Director, Capital Markets

FWD

T - 020 7280 0651 / 07714 770 493

E - roddy.watt@fwdconsulting.co.uk

Notes to Editors

Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured and CASLP in the UK, as The Waard Group and Scildon in the Netherlands and as Movestic in Sweden.

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 18 years in succession.

Further details are available on the Company's website ( www.chesnara.co.uk ).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

AGMNKQBDFBDDODD

(END) Dow Jones Newswires

November 15, 2023 02:00 ET (07:00 GMT)

1 Year Chesnara Chart

1 Year Chesnara Chart

1 Month Chesnara Chart

1 Month Chesnara Chart

Your Recent History

Delayed Upgrade Clock